观点网讯：6月19日，复星医药宣布其控股子公司复星医药新加坡公司通过大宗交易出售了所持有的Gland Pharma Limited的9,900,000股股份，占Gland Pharma Limited总股权的6.01%。
此次交易的均价为1,771.81印度卢比/股，总对价达到175.41亿印度卢比，折合大约2.11亿美元。
复星医药出售印度公司6.01%股权 交易额约2.11亿美元
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.